(Adalimumab)Biosimilar Reference Antibody 新品

货号：GS40010

Adalimumab is a recombinant, fully human IgG1 monoclonal antibody that revolutionized the treatment of chronic inflammatory diseases. It functions as a high-affinity antagonist that specifically binds to and neutralizes soluble and membrane-bound tumor necrosis factor-alpha (TNF-α), a central pro-inflammatory cytokine. Marketed under the brand name Humira, it has become one of the world's best-selling pharmaceuticals, approved for a wide range of autoimmune conditions including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, and hidradenitis suppurativa.